Levobunolol hydrochloride
CAS No. 27912-14-7
Levobunolol hydrochloride ( l-Bunolol hydrochloride )
Catalog No. M26738 CAS No. 27912-14-7
Levobunolol hydrochloride is a non-selective beta-blocker and is used topically to manage glaucoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 51 | Get Quote |
|
50MG | 98 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLevobunolol hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevobunolol hydrochloride is a non-selective beta-blocker and is used topically to manage glaucoma.
-
DescriptionLevobunolol hydrochloride is a non-selective beta-blocker and is used topically to manage glaucoma.
-
Synonymsl-Bunolol hydrochloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorMAO-B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27912-14-7
-
Formula Weight327.9
-
Molecular FormulaC17H26ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tzvetkov NT, et al. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. J Med Chem. 2014 Aug 14;57(15):6679-703.
molnova catalog
related products
-
beta-Hydroxyacteosid...
beta-Hydroxyacteoside.
-
Oxysophocarpine
Oxysophocarpine is extracted from Sophra flavescens Ait.
-
BAY 2416964
BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1 (example 192, IC50: 341 nM). It has the potential for cancer treatment.BAY 2416964 induces AHR-regulated gene CYP1A1 expression in human monocytic U937 cells (IC50: 4.3 nM).